What is it about?
A retrospective examination of how statins may modulate cognition in Parkinson's disease longitudinally
Featured Image
Why is it important?
It is the first example of how statins may slow the rate of cognitive decline in Parkinson's disease
Perspectives
Constructing this manuscript was a large project and required many hours of diligent work for data cleaning and analyses. The manuscript suggests that individuals using statins may have a greater likelihood for slowing the rate of cognitive decline, a massive issue in Parkinson's disease.
Benjamin Deck
University of Pennsylvania
Read the Original
This page is a summary of: Statins and Cognition in Parkinson’s Disease, Journal of Parkinson’s Disease, November 2017, IOS Press,
DOI: 10.3233/jpd-171113.
You can read the full text:
Contributors
The following have contributed to this page
